- ongoing, recruitingTherapeutic exploratory (Phase II)
A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO study)
This study is testing a new eye drop for dry eye disease. It uses a man-made version of a natural body substance to see if it improves dry eye symptoms and overall eye health over 8 weeks, with a follow-up period.
Italy - not yet recruitingNA
Study of Blinking as a Function of Tear Film Quality
This study looks at how your blinks affect how well your tears coat your eyes, especially for people with or without dry eyes. Researchers will compare blinking in these groups to understand more about dry eye.
France